Single- and multiple-dose pharmacokinetics, pharmacodynamics, and safety of apixaban in healthy Chinese subjects [Corrigendum]

por Cui Y, Song Y, Wang J, Yu Z, Schuster A, Barrett YC, Frost C
Publicado 2014

Single- and multiple-dose pharmacokinetics, pharmacodynamics, and safety of apixaban in healthy Chinese subjects

por Cui Y, Song Y, Wang J, Yu Z, Schuster A, Barrett YC, Frost C
Publicado 2013

A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban [Corrigendum]

por Frost C, Song Y, Barrett YC, Wang J, Pursley J, Boyd RA, LaCreta F
Publicado 2018

A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban

por Frost C, Song Y, Barrett YC, Wang J, Pursley J, Boyd RA, LaCreta F
Publicado 2014

Evaluation of the single-dose pharmacokinetics and pharmacodynamics of apixaban in healthy Japanese and Caucasian subjects

por Frost C, Shenker A, Jhee S, Yu Z, Wang J, Bragat A, Pursley J, LaCreta F
Publicado 2018

The effect of apixaban on the pharmacokinetics of digoxin and atenolol in healthy subjects

por Frost C, Song Y, Yu Z, Wang J, Lee LS, Schuster A, Pollack A, LaCreta F
Publicado 2017